SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Check Before You Invest : Mukka Proteins Ltd

BSE: 544135 NSE: MUKKA ISIN: INE0CG401037
  |   Sector:  FMCG   |   Industry:  Animal Feed

Snapshot

Q.1 Which industry/sub-sector does Mukka Proteins Ltd belong to?
Mukka Proteins Ltd belongs to the FMCG sector, operating specifically within the Animal Feed segment.
Q.2 Is Mukka Proteins Ltd a good quality company?
Mukka Proteins Ltd is a weak quality company, based on a inconsistent 7-year financial track record.
Q.3 Is Mukka Proteins Ltd undervalued or overvalued?
Mukka Proteins Ltd appears Fair, as its key valuation ratios are in line with their past averages.
Q.4 Is Mukka Proteins Ltd a good buy now?
Mukka Proteins Ltd is a neutral opportunity now, based on stable price trend analysis suggesting prices may move sideways. However, you need to check its quality and valuation before making a decision

Performance Analysis

Q.1 Revenue growth of Mukka Proteins Ltd?
Mukka Proteins Ltd revenue growth is -30.1% for FY-2025, which is below its 5-year CAGR of 10.2%, indicating slower growth.
Q.2 Return on capital employed (ROCE) of Mukka Proteins Ltd?
Mukka Proteins Ltd Return on capital employed is 11.49% for FY-2025, which is below its 5-year historical median of 16.92%. The current ROCE is below its estimated weighted average cost of capital (WACC) of 14%, indicating value preservation.
Q.3 Return on Asset of Mukka Proteins Ltd?
Mukka Proteins Ltd Return on Asset is 4.57%, which is below its 5-year historical median of 6.42%, indicating deteriorated asset utilization efficiency.
Q.4 Return on Equity (ROE) of Mukka Proteins Ltd?
Mukka Proteins Ltd Return on equity is 10.83% for FY-2025, which is below its 5-year historical median of 25.78%, indicating the business is making worse use of its shareholders capital.
Q.5 Cash conversion cycle of Mukka Proteins Ltd?
Mukka Proteins Ltd Cash conversion cycle is 204 days, above its 5-year historical median of 58 days, indicating deteriorated working capital management. However, you need to compare this with its peers in the industry.
Current Level 5-year
Historic Median
Asset Turnover 0.95 1.97
ROE 10.83 25.78
ROCE 11.49 16.92
Cash Conversion Cycle 204 days 58 days
Q.6 Gross Profit margin of Mukka Proteins Ltd?
Mukka Proteins Ltd Gross profit margin which is the profit after deduction of direct costs, is 6.7% for FY-2025, which is above its 5-year median of 5.4%, indicating increasing margins.
Q.7 Operating Profit Margin of Mukka Proteins Ltd?
Mukka Proteins Ltd Operating Profit Margin which is the profit after deduction of all operating costs, is 8.59% for FY-2025, which is above its 5-year median of 6.42% indicating increasing margins.
Q.8 Net Profit Margin of Mukka Proteins Ltd?
Mukka Proteins Ltd Net Profit Margin is 4.7% for FY-2025, is above with its 5-year median of 3.7%, indicating increasing margins.
Current Level 5-year
Historic Median
Gross Profit Margin 6.7 5.4
Operating Profit Margin 8.59 6.42
Net Profit Margin 4.7 3.7
Q.9 Debt to Equity ratio of Mukka Proteins Ltd?
Mukka Proteins Ltd Debt-to-Equity ratio is 1.03, which is above with the industry average of 0.12, indicating higher debt levels in the industry.
Q.10 Debt to cash flow from operations of Mukka Proteins Ltd?
Mukka Proteins Ltd Debt to cash flow from operations is -3.14, which is at a unhealthy level.

Ownership & governance

Q.1 Promoter shareholding and pledge status of Mukka Proteins Ltd?
Promoters hold 73.33% of the Mukka Proteins Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Peer comparison (industry-wise, mcap)

Q.1 Revenue growth of Mukka Proteins Ltd vs industry peers?
Mukka Proteins Ltd revenue CAGR is 10.20%, compared to the industry median CAGR of 6.14%, indicating faster growth and gaining its market share.
Profit Metrics
Current Level 5-year
Industry Median
Revenue Growth -30.1 6.1
Gross Profit Growth -21.6 8.8
Operating Profit Growth -6.2 10.7
Net Profit Growth -33.3 7.6
Operating Efficiency
Current Level 5-year
Industry Median
Asset Turnover 0.95 1.76
ROE 10.83 12.91
ROCE 11.49 11.94
Cash Conversion Cycle (days) 204.47 31

Valuation & price assessment

Q.1 Stock return of Mukka Proteins Ltd over the last decade?
Over the last 1 year(s), the stock has delivered a CAGR of -18.79% based on the current price.
Q.2 What return has the stock given over the last decade?
9Y 5Y 3Y 1Y
Share Price
CAGR
- - - -18.8%
Q.3 Valuation ratios of Mukka Proteins Ltd vs historical?
The current P/E is similar that its historical median.
Q.4 How do the current valuation ratios compare with 5-year historical median and industry numbers?
Valuation Ratios Current 5-year
Historic Median
5-year
Industry Median
Price to Earnings 20.39 20.36 20.37
Price to Book 1.72 2.58 2.73
Price to Sales 0.61 1.02 1.07
EV to EBITDA 12.57 14.06 14.06

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×